References
- Cady B. New diagnostic, staging, and therapeutic aspects of early breast cancer. Cancer 1990; 65: 634–47
- Henderson IC. Adjuvant systemic therapy: State of the art, 1989. Breast Cancer Res Treat 1989; 14: 3–22
- Merkel D E, Osborne CK. Prognostic factors in breast cancer. Hematol Oncol Clin North Am 1989; 3: 641–52
- Howell A, Millis RR. Cellular aspects of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 21–8
- Tondini C, Hayes D F, Kufe D. Circulating tumor markers in breast cancer. Hematol Oncol Clin North Am 1989; 3: 653–74
- Kiang D T, Greenberg L J, Kennedy BJ. Tumor marker kinetics in the monitoring of breast cancer. Cancer 1990; 65: 193–9
- Lea O A, Thorsen T, Kvinnsland S. Extracellular proteins in breast tumor cytosol. Anticancer Res 1987; 7: 113–8
- Spyratos F, Maudelonde T, Brouillet J-P, et al. Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet 1989; 2: 1115–8
- Slamon D J, Clark G M, Wong S G, et al. Human breast cancer: Correlation of relapse and survival with amplification of HER-2/neu oncogene. Science 1987; 235: 177–82
- Depotter C R, Beghin C, Makar A P, Vandekerckhove D, Roels HJ. The neu-oncogene protein as a predictive factor for hematogeneous metastases in breast cancer patients. Int J Cancer 1990; 45: 55–8
- Reed R K, Wiig H. Interstitial albumin mass and transcapillary extravasation rate of albumin in DMBA-induced rat mammary tumours. Scand J Clin Lab Invest 1983; 43: 503–12
- Haraldsson B, Regner L, Hultborn R, Weiss L, Rippe B. Transcapillary passage of albumin in mammary tumours and in normal lactating mammary glands of the rat. Acta Physiol Scand 1984; 122: 497–505
- Etzrodt A, Jung H, Tolxdorff T, Bigalke LH. The importance of albumin concentration for axillary metastasis. Geburtshilfe Frauenheilkd 1983; 43: 670–3
- Vercelli-Retta J, Manana G, Almeida E, Chiribao C, Estvez A, Moro R. Normal serum proteins in female breast carcinomas and fibroadenomas. An immunohistochemical study. Ann Pathol 1987; 7: 209–15
- UICC. TNM classification of malignant tumours.4th edition. Springer Verlag, New York, Berlin 1987
- Sedmark J J, Grossberg SE. A rapid, sensitive and versatile assay for protein using Coomassie Brilliant Blue G250. Anal Biochem 1977; 10: 544–52
- Laurell CB. Quantitative estimation of proteins by electrophoresis and agarose gels containing antibodies. Anal Biochem 1986; 15: 45–52
- Thorsen T. Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: Relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem 1979; 10: 661–8
- Kalbfleisch J D, Prentice RL. The statistical analysis of failure time data. Wiley, New York 1980
- Cox DR. Analysis of binary data, section 6.6. Chapman & Hall, London 1970
- Fiszer-Szafarz B, Szafarz D. DNA and protein content as cellular biochemical parameters. A discussion with two examples: Acid phosphatase and Cathepsin D in rat liver and hepatoma and acid phosphatase in human breast normal tissue and adenocarcinoma. Anal Biochem 1984; 138: 255–8
- Parham D M, Baker P R, Robertson A J, Vasishta A, Baker PG. Breast carcinoma cellularity and its relation to oestrogen receptor content. J Clin Pathol 1989; 42: 1166–8
- Osborne CK. Receptors. Breast diseases, JR. Harris, S. Hellman, IC. Henderson, DW. Kinne. JB Lippincott, Philadelphia 1987; 210–32
- Uriel J, Fally-Crepin C, Villacampa M J, Pineiro A, Geuskens M. Incorporation of alpha-fetoprotein by the MCF-7 human breast cancer cell line. Tumour Biol 1984; 5: 41–51
- Etzrodt A, Bigalke L H, Jung H, Tolxdorff T. Occurence and distribution of plasma proteins in malignant and benign breast tissue. Tumor Diagn Ther 1983; 4: 109–13
- Winsten S, Tabachnick J, Young I. Immunoglobulin G (IgG) levels in breast tumor cytosols. Am J Clin Pathol 1985; 83: 364–6